Involvement of Hyaluronan in Regulation of Fibroblast Phenotype
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
This study aimed to understand the role of the matrix polysaccharide, hyaluronan (HA), in influencing the scarring process by assessing its impact on regulating fibroblast behavior. Donor-matched human oral and dermal fibroblasts were used as models of nonscarring and scarring fibroblast phenotypes, respectively. Phenotypic differences in these two fibroblast populations were assessed and related to differences in HA synthesis and assembly. The two fibroblast populations showed intrinsic differences in their response to the profibrotic cytokine, transforming growth factor-beta1 (TGFbeta1), in that oral fibroblasts were resistant to TGFbeta1-driven myofibroblastic differentiation. In dermal fibroblasts, differentiation was associated with an induction of HA synthase (HAS1 and HAS2) transcription and assembly of pericellular HA coats. In comparison, resistance to differentiation in oral fibroblasts was associated with failure of induction of HAS1 and HAS2 transcription and failure of pericellular coat assembly. Furthermore, inhibition of HA synthesis in dermal fibroblasts significantly attenuated TGFbeta1-mediated differentiation. Interleukin-1beta stimulation resulted in induction of HAS1 and HAS2 transcription but did not induce phenotypic differentiation or induce HA coat assembly. In addition, neither overexpression nor down-regulation of HAS1 (the isoform uniquely deficient in nonscarring oral fibroblasts) influenced phenotypic differentiation. In conclusion, inhibiting HA synthesis modulates TGFbeta1-dependent responses in these cells preventing fibroblast to myofibroblast differentiation. Moreover, HA pericellular coat assembly, rather than HAS isoform expression, appears to be associated with phenotypic differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
Cited by
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound
Tracy, L. E., Minasian, R. A., & Caterson, E. J. (2016) · Advances in Wound Care · doi:10.1089/wound.2014.0561 · Cited by 1,008
“A quantitative proteomics study revealed that sulfated HA upregulates 84 proteins, and downregulates various MMPs and collagen I.109 These effects are likely related, in part, to the ability of sulfated HA to bind even more avidly to TGF-b1 than does native HA.110 Investigation of artificial tissue scaffolds containin…”
BackgroundThe extracellular matrix: an active or passive player in fibrosis?
Wight, T. N., & Potter-Perigo, S. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00132.2011 · Cited by 657
The extracellular matrix as a multitasking player in disease
Theocharis, A. D., Manou, D., & Karamanos, N. K. (2019) · The FEBS Journal · doi:10.1111/febs.14818 · Cited by 511
Fibroblasts and myofibroblasts in renal fibrosis
Meran, S., & Steadman, R. (2011) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2011.00764.x · Cited by 346
Self-citationMidgley, A. C., Rogers, M., Hallett, M. B., Clayton, A., Bowen, T., Phillips, A. O., & Steadman, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.451336 · Cited by 296
Self-citationFibroblast heterogeneity and its implications for engineering organotypic skin models in vitro
Sriram, G., Bigliardi, P. L., & Bigliardi-Qi, M. (2015) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2015.08.001 · Cited by 269
OHARA, H., ICHIKAWA, S., MATSUMOTO, H., AKIYAMA, M., FUJIMOTO, N., KOBAYASHI, T., & TAJIMA, S. (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2010.00827.x · Cited by 255
Myofibroblasts: Function, Formation, and Scope of Molecular Therapies for Skin Fibrosis
Tai, Y., Woods, E. L., Dally, J., Kong, D., Steadman, R., Moseley, R., & Midgley, A. C. (2021) · Biomolecules · doi:10.3390/biom11081095 · Cited by 240
“fibroblasts; these cells exhibited an anti-proliferative response in a HA/CD44-independent manner [65].”
BackgroundSelf-citationHyaluronan: More than just a wrinkle filler
Maytin, E. V. (2016) · Glycobiology · doi:10.1093/glycob/cww033 · Cited by 128
Hyaluronan synthase 2 regulates fibroblast senescence in pulmonary fibrosis
Li, Y., Liang, J., Yang, T., Monterrosa Mena, J., Huan, C., Xie, T., Kurkciyan, A., Liu, N., Jiang, D., & Noble, P. W. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.03.004 · Cited by 93
Metadata
- Authors
- Meran, S., Thomas, D., Stephens, P., Martin, J., Bowen, T., Phillips, A., & Steadman, R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 282
- Issue
- 35
- Pages
- 25687-25697
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1992635362
- Cited by
- 146
- References
- 1
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.